AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Cohen & Steers Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

UnitedHealth Group (UNH) â€� Form 4 insider transaction.

CEO and Director Stephen J. Hemsley reported the acquisition of 198 deferred stock units on 07/01/2025 as part of his regular quarterly board compensation. These units are immediately vested but must be held until he leaves the Board, and the filing shows $0 purchase price (non-cash grant).

Following the award, Hemsley’s beneficial ownership stands at:

  • 374,605.942 shares held directly
  • 349.7176 shares held through the company 401(k)
  • 735,115 shares held via family trusts

No derivative securities were reported, and there were no sales or open-market purchases. The filing appears to be routine compensation-related and does not indicate any change in strategic outlook or financial performance for UnitedHealth Group.

UnitedHealth Group (UNH) � Transazione interna Form 4.

Il CEO e Direttore Stephen J. Hemsley ha segnalato l'acquisizione di 198 unità azionarie differite il 01/07/2025 come parte della sua consueta remunerazione trimestrale del consiglio. Queste unità sono immediatamente maturate, ma devono essere mantenute fino alla sua uscita dal Consiglio, e la dichiarazione indica un prezzo di acquisto pari a $0 (concessione non in denaro).

Dopo l'assegnazione, la proprietà effettiva di Hemsley è la seguente:

  • 374.605,942 azioni detenute direttamente
  • 349,7176 azioni detenute tramite il piano 401(k) aziendale
  • 735.115 azioni detenute tramite trust familiari

Non sono stati segnalati titoli derivati, né vendite o acquisti sul mercato aperto. La dichiarazione sembra essere una normale operazione legata alla remunerazione e non indica alcun cambiamento nella strategia o nelle prestazioni finanziarie di UnitedHealth Group.

UnitedHealth Group (UNH) � Transacción interna Formulario 4.

El CEO y Director Stephen J. Hemsley informó la adquisición de 198 unidades de acciones diferidas el 01/07/2025 como parte de su compensación trimestral habitual por su puesto en el consejo. Estas unidades están inmediatamente consolidadas, pero deben mantenerse hasta que deje el Consejo, y el informe muestra un precio de compra de $0 (concesión sin efectivo).

Tras la adjudicación, la propiedad efectiva de Hemsley es:

  • 374,605.942 acciones en propiedad directa
  • 349.7176 acciones a través del plan 401(k) de la empresa
  • 735,115 acciones a través de fideicomisos familiares

No se reportaron valores derivados, ni ventas o compras en el mercado abierto. El informe parece ser una operación rutinaria relacionada con la compensación y no indica ningún cambio en la perspectiva estratégica o el desempeño financiero de UnitedHealth Group.

UnitedHealth Group (UNH) � 내부� 거래 Form 4 보고.

CEO ê²� ì´ì‚¬ì� Stephen J. Hemsleyê°€ 2025ë…� 7ì›� 1ì� 정기 분기 ì´ì‚¬íš� ë³´ìƒìœ¼ë¡œ 198ê°œì˜ ì´ì—° ì£¼ì‹ ë‹¨ìœ„ë¥� ì·¨ë“했다ê³� 보고했습니다. ì� ë‹¨ìœ„ë“¤ì€ ì¦‰ì‹œ ì·¨ë“ë˜ì§€ë§� 그가 ì´ì‚¬íšŒì—ì„� 물러ë‚� 때까지 보유해야 하며, 신고서ì—ëŠ� 구매 ê°€ê²� $0(현금ì� 아닌 ë¶€ì—�)ë¡� 표시ë˜ì–´ 있습니다.

ë³´ìƒ ì´í›„ Hemsleyì� 실질 소유 주ì‹ì€ 다ìŒê³� 같습니다:

  • 374,605.942 ì£� ì§ì ‘ 보유
  • 349.7176 ì£� 회사 401(k)ë¥� 통해 보유
  • 735,115 ì£� ê°€ì¡� ì‹ íƒì� 통해 보유

íŒŒìƒ ì¦ê¶Œì€ ë³´ê³ ë˜ì§€ 않았으며, 매ë„ë‚� 공개 시장 매수ë� 없었습니ë‹�. ì´ë²ˆ ì‹ ê³ ëŠ� ë³´ìƒê³� ê´€ë ¨ëœ ì¼ìƒì ì¸ 거래ë¡� ë³´ì´ë©� UnitedHealth Groupì� ì „ëžµì � ì „ë§ì´ë‚˜ 재무 성과 변화는 나타나지 않습니다.

UnitedHealth Group (UNH) � Transaction d’initié Formulaire 4.

Le PDG et administrateur Stephen J. Hemsley a déclaré l’acquisition de 198 unités d’actions différées le 01/07/2025 dans le cadre de sa rémunération trimestrielle habituelle en tant que membre du conseil. Ces unités sont immédiatement acquises mais doivent être conservées jusqu’� son départ du conseil, et le dossier indique un prix d’achat de 0 $ (attribution non monétaire).

Après cette attribution, la propriété bénéficiaire de Hemsley se compose de :

  • 374 605,942 actions détenues directement
  • 349,7176 actions détenues via le plan 401(k) de l’entreprise
  • 735 115 actions détenues par des trusts familiaux

Aucun titre dérivé n’a été déclaré, et il n’y a eu ni ventes ni achats sur le marché ouvert. Le dossier semble être une opération courante liée à la rémunération et n’indique aucun changement dans les perspectives stratégiques ou la performance financière de UnitedHealth Group.

UnitedHealth Group (UNH) � Insider-Transaktion Form 4.

CEO und Direktor Stephen J. Hemsley meldete am 01.07.2025 den Erwerb von 198 aufgeschobenen Aktienanteilen im Rahmen seiner regulären vierteljährlichen Vergütung als Vorstandsmitglied. Diese Einheiten sind sofort unverfallbar, müssen jedoch bis zu seinem Ausscheiden aus dem Vorstand gehalten werden, und die Meldung weist einen Kaufpreis von 0 $ (nicht barer Zuschuss) aus.

Nach der Zuteilung beläuft sich Hemsleys wirtschaftliches Eigentum auf:

  • 374.605,942 direkt gehaltene Aktien
  • 349,7176 Aktien über den firmeninternen 401(k)
  • 735.115 Aktien über Familientrusts

Es wurden keine Derivate gemeldet, ebenso keine Verkäufe oder Käufe am offenen Markt. Die Meldung erscheint routinemäßig und im Zusammenhang mit der Vergütung zu stehen, ohne Hinweise auf Änderungen der strategischen Ausrichtung oder der finanziellen Lage von UnitedHealth Group.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine director compensation grant; immaterial size, neutral signal.

The 198-unit deferred stock grant to CEO/Director Stephen Hemsley is a standard quarterly award that vests immediately but is locked up until board service ends. With existing direct and indirect ownership exceeding 1.1 million shares, this grant is de-minimis (<0.02 % of his holdings) and involves no cash outlay. It neither changes insider sentiment nor alters the company’s share supply. For investors, the filing is non-impactful and should not influence valuation or trading decisions.

UnitedHealth Group (UNH) � Transazione interna Form 4.

Il CEO e Direttore Stephen J. Hemsley ha segnalato l'acquisizione di 198 unità azionarie differite il 01/07/2025 come parte della sua consueta remunerazione trimestrale del consiglio. Queste unità sono immediatamente maturate, ma devono essere mantenute fino alla sua uscita dal Consiglio, e la dichiarazione indica un prezzo di acquisto pari a $0 (concessione non in denaro).

Dopo l'assegnazione, la proprietà effettiva di Hemsley è la seguente:

  • 374.605,942 azioni detenute direttamente
  • 349,7176 azioni detenute tramite il piano 401(k) aziendale
  • 735.115 azioni detenute tramite trust familiari

Non sono stati segnalati titoli derivati, né vendite o acquisti sul mercato aperto. La dichiarazione sembra essere una normale operazione legata alla remunerazione e non indica alcun cambiamento nella strategia o nelle prestazioni finanziarie di UnitedHealth Group.

UnitedHealth Group (UNH) � Transacción interna Formulario 4.

El CEO y Director Stephen J. Hemsley informó la adquisición de 198 unidades de acciones diferidas el 01/07/2025 como parte de su compensación trimestral habitual por su puesto en el consejo. Estas unidades están inmediatamente consolidadas, pero deben mantenerse hasta que deje el Consejo, y el informe muestra un precio de compra de $0 (concesión sin efectivo).

Tras la adjudicación, la propiedad efectiva de Hemsley es:

  • 374,605.942 acciones en propiedad directa
  • 349.7176 acciones a través del plan 401(k) de la empresa
  • 735,115 acciones a través de fideicomisos familiares

No se reportaron valores derivados, ni ventas o compras en el mercado abierto. El informe parece ser una operación rutinaria relacionada con la compensación y no indica ningún cambio en la perspectiva estratégica o el desempeño financiero de UnitedHealth Group.

UnitedHealth Group (UNH) � 내부� 거래 Form 4 보고.

CEO ê²� ì´ì‚¬ì� Stephen J. Hemsleyê°€ 2025ë…� 7ì›� 1ì� 정기 분기 ì´ì‚¬íš� ë³´ìƒìœ¼ë¡œ 198ê°œì˜ ì´ì—° ì£¼ì‹ ë‹¨ìœ„ë¥� ì·¨ë“했다ê³� 보고했습니다. ì� ë‹¨ìœ„ë“¤ì€ ì¦‰ì‹œ ì·¨ë“ë˜ì§€ë§� 그가 ì´ì‚¬íšŒì—ì„� 물러ë‚� 때까지 보유해야 하며, 신고서ì—ëŠ� 구매 ê°€ê²� $0(현금ì� 아닌 ë¶€ì—�)ë¡� 표시ë˜ì–´ 있습니다.

ë³´ìƒ ì´í›„ Hemsleyì� 실질 소유 주ì‹ì€ 다ìŒê³� 같습니다:

  • 374,605.942 ì£� ì§ì ‘ 보유
  • 349.7176 ì£� 회사 401(k)ë¥� 통해 보유
  • 735,115 ì£� ê°€ì¡� ì‹ íƒì� 통해 보유

íŒŒìƒ ì¦ê¶Œì€ ë³´ê³ ë˜ì§€ 않았으며, 매ë„ë‚� 공개 시장 매수ë� 없었습니ë‹�. ì´ë²ˆ ì‹ ê³ ëŠ� ë³´ìƒê³� ê´€ë ¨ëœ ì¼ìƒì ì¸ 거래ë¡� ë³´ì´ë©� UnitedHealth Groupì� ì „ëžµì � ì „ë§ì´ë‚˜ 재무 성과 변화는 나타나지 않습니다.

UnitedHealth Group (UNH) � Transaction d’initié Formulaire 4.

Le PDG et administrateur Stephen J. Hemsley a déclaré l’acquisition de 198 unités d’actions différées le 01/07/2025 dans le cadre de sa rémunération trimestrielle habituelle en tant que membre du conseil. Ces unités sont immédiatement acquises mais doivent être conservées jusqu’� son départ du conseil, et le dossier indique un prix d’achat de 0 $ (attribution non monétaire).

Après cette attribution, la propriété bénéficiaire de Hemsley se compose de :

  • 374 605,942 actions détenues directement
  • 349,7176 actions détenues via le plan 401(k) de l’entreprise
  • 735 115 actions détenues par des trusts familiaux

Aucun titre dérivé n’a été déclaré, et il n’y a eu ni ventes ni achats sur le marché ouvert. Le dossier semble être une opération courante liée à la rémunération et n’indique aucun changement dans les perspectives stratégiques ou la performance financière de UnitedHealth Group.

UnitedHealth Group (UNH) � Insider-Transaktion Form 4.

CEO und Direktor Stephen J. Hemsley meldete am 01.07.2025 den Erwerb von 198 aufgeschobenen Aktienanteilen im Rahmen seiner regulären vierteljährlichen Vergütung als Vorstandsmitglied. Diese Einheiten sind sofort unverfallbar, müssen jedoch bis zu seinem Ausscheiden aus dem Vorstand gehalten werden, und die Meldung weist einen Kaufpreis von 0 $ (nicht barer Zuschuss) aus.

Nach der Zuteilung beläuft sich Hemsleys wirtschaftliches Eigentum auf:

  • 374.605,942 direkt gehaltene Aktien
  • 349,7176 Aktien über den firmeninternen 401(k)
  • 735.115 Aktien über Familientrusts

Es wurden keine Derivate gemeldet, ebenso keine Verkäufe oder Käufe am offenen Markt. Die Meldung erscheint routinemäßig und im Zusammenhang mit der Vergütung zu stehen, ohne Hinweise auf Änderungen der strategischen Ausrichtung oder der finanziellen Lage von UnitedHealth Group.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dolly Lisa

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/01/2025 A 360(1) A $0 1,144 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many UnitedHealth Group shares did Stephen J. Hemsley acquire on 07/01/2025?

198 deferred stock units were granted as part of regular board compensation.

What is Stephen J. Hemsley’s total direct ownership in UNH after the transaction?

He now holds 374,605.942 shares directly.

Were any UnitedHealth Group shares sold in this Form 4 filing?

No. The filing reports only an acquisition; no sales occurred.

Does the Form 4 indicate open-market purchases by the CEO?

No. The units were a non-cash, board compensation grant with a $0 price.

How many shares does Hemsley hold indirectly through trusts and the 401(k)?

He holds 735,115 shares via trusts and 349.7176 shares in the 401(k).
Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Latest News

CNS Latest SEC Filings

CNS Stock Data

3.89B
27.43M
46.43%
59.41%
3.52%
Asset Management
Investment Advice
United States
NEW YORK